Surgical Robot Regs To Be Addressed At FDA Gathering
This article was originally published in The Gray Sheet
Executive Summary
The agency plans to tackle major issues related to robotically-assisted surgical devices such as safety and efficacy requirements as well as proper surgical training in what it describes is a “rapidly-developing field” during a two-day summer workshop.
You may also be interested in...
Robot-Assisted Kidney Surgery Reduces Deaths, But Comparative Data Missing, Says Economist
Robot-assisted surgery for kidney cancers improves outcomes by allowing partial nephrectomies, reducing mortalities and lowering some health care costs said economist Julia Thornton Snider at a Feb. 5 biomedical innovation meeting, but researchers did not compare robotic surgeries with laparoscopic or open surgeries, nor did they examine costs of deaths or other bad patient outcomes linked to robotic surgeries.
FDA Surgeon Survey Finds Variation In Training With da Vinci System
An FDA survey of 11 surgeons with experience using Intuitive Surgical’s da Vinci robotic surgical system shows respondents reported having difficulty learning how to use the device’s complex user interface.
FDA Investigates Adverse Events Reported With Da Vinci Robot
An apparent increase in adverse event reports with Intuitive Surgical’s popular robotic surgery system has triggered further inquiry from FDA.